Champions Oncology Share Price Today
(NASDAQ: CSBR)

Name: Champions Oncology Share Price Today (NASDAQ: CSBR) - Champions Oncology Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Champions Oncology share price is $10.4 & ₹904.48 as on 6 Mar 2025, 2.30 'hrs' IST

$10.4

▲

0.07

(0.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Champions Oncology share price in Dollar and Rupees. Guide to invest in Champions Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Champions Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Champions Oncology share price movements

Today's Low: $10.00
Today's High: $10.62
$10.40
3.85%
Downside
Day's Volatility :5.8%
Upside
2.03%
52 Weeks Low: $3.60
52 Weeks High: $11.99
$10.40
65.38%
Downside
52 Weeks Volatility :69.97%
Upside
13.26%

Champions Oncology (CSBR) Returns

Period	Champions Oncology Inc	Index (Russel 2000)
3 Months	138.02%	0.0%
6 Months	143.06%	0.0%
1 Year	84.73%	0.0%
3 Years	21.1%	-11.6%

Champions Oncology (CSBR) Key Statistics

in dollars & INR

Previous Close	$10.33
Open	$10.3
Today's High	$10.6157
Today's Low	$10.0
Market Capitalization	$141.5M
Today's Volume	$10.1K
52 Week High	$11.99
52 Week Low	$3.6001
Revenue TTM	$53.6M
EBITDA	$1.4M
Earnings Per Share (EPS)	$-0.05
Profit Margin	-1.12%
Quarterly Earnings Growth YOY	-0.29%
Return On Equity TTM	-154.52%

How to invest in Champions Oncology Stock (CSBR) from India?

It is very easy for Indian residents to invest directly in Champions Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Champions Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Champions Oncology or CSBR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Champions Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Champions Oncology shares which would translate to 0.084 fractional shares of Champions Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Champions Oncology, in just a few clicks!

Returns in Champions Oncology (CSBR) for Indian investors in Rupees

The Champions Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Champions Oncology investment value today

Current value as on today

₹1,91,009

Returns

₹91,009

(+91.01%)

Returns from Champions Oncology Stock

₹86,047 (+86.05%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Champions Oncology (CSBR)

-31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Champions Oncology Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Champions Oncology

Battery Management Corp
17.68%
NEA Management Company, LLC
12.51%
Tocqueville Asset Management L.P.
4.45%
Vanguard Group Inc
2.24%
Renaissance Technologies Corp
1.01%
BlackRock Inc
0.85%

Analyst Recommendation on Champions Oncology

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Champions Oncology(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Champions Oncology Stock (CSBR)

What analysts predicted

Downside of 23.08%

Target:

$8.00

Current:

$10.40

Insights on Champions Oncology Stock (Ticker Symbol: CSBR)

Price Movement
In the last 3 months, CSBR stock has moved up by 138.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 14.06M → 13.48M (in $), with an average decrease of 4.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.31M → 728.0K (in $), with an average decrease of 44.6% per quarter
CSBR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 20.8%

CSBR Champions Oncology Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$27.1M	↑ 33.72%
Net Income	$128.0K	↓ 108.5%
Net Profit Margin	0.47%	↑ 7.91%

	FY20	Y/Y Change
Revenue	$32.1M	↑ 18.68%
Net Income	$-2.0M	↓ 1642.97%
Net Profit Margin	-6.15%	↓ 6.62%

	FY21	Y/Y Change
Revenue	$41.0M	↑ 27.76%
Net Income	$362.0K	↓ 118.33%
Net Profit Margin	0.88%	↑ 7.03%

	FY22	Y/Y Change
Revenue	$49.1M	↑ 19.66%
Net Income	$548.0K	↑ 51.38%
Net Profit Margin	1.12%	↑ 0.24%

	FY23	Y/Y Change
Revenue	$53.9M	↑ 9.69%
Net Income	$-5.3M	↓ 1073.54%
Net Profit Margin	-9.9%	↓ 11.02%

	FY24	Y/Y Change
Revenue	$50.2M	↓ 6.9%
Net Income	$-7.3M	↑ 36.38%
Net Profit Margin	-14.51%	↓ 4.61%

	Q3 FY23	Q/Q Change
Revenue	$12.6M	↓ 3.9%
Net Income	$-2.6M	↑ 0.2%
Net Profit Margin	-20.43%	↓ 0.84%

	Q4 FY23	Q/Q Change
Revenue	$11.6M	↓ 7.87%
Net Income	$-2.1M	↓ 19.29%
Net Profit Margin	-17.9%	↑ 2.53%

	Q1 FY24	Q/Q Change
Revenue	$12.0M	↑ 3.85%
Net Income	$-2.5M	↑ 22.16%
Net Profit Margin	-21.05%	↓ 3.15%

	Q2 FY24	Q/Q Change
Revenue	$14.0M	↑ 16.49%
Net Income	$-109.0K	↓ 95.69%
Net Profit Margin	-0.78%	↑ 20.27%

	Q3 FY24	Q/Q Change
Revenue	$14.1M	↑ 0.43%
Net Income	$1.3M	↓ 1304.59%
Net Profit Margin	9.34%	↑ 10.12%

	Q4 FY24	Q/Q Change
Revenue	$13.5M	↓ 4.07%
Net Income	$728.0K	↓ 44.55%
Net Profit Margin	5.4%	↓ 3.94%

	FY19	Y/Y Change
Profit	$12.8M	↑ 32.14%

	FY20	Y/Y Change
Profit	$15.2M	↑ 19.05%

	FY21	Y/Y Change
Profit	$19.6M	↑ 28.38%

	FY22	Y/Y Change
Profit	$25.5M	↑ 30.21%

	FY23	Y/Y Change
Profit	$24.3M	↓ 4.47%

	FY24	Y/Y Change
Profit	$20.8M	↓ 14.73%

	Q3 FY23	Q/Q Change
Profit	$4.9M	↓ 14.95%

	Q4 FY23	Q/Q Change
Profit	$5.0M	↑ 1.6%

	Q1 FY24	Q/Q Change
Profit	$4.2M	↓ 15.84%

	Q2 FY24	Q/Q Change
Profit	$6.8M	↑ 61.89%

	Q3 FY24	Q/Q Change
Profit	$7.0M	↑ 3.53%

	Q4 FY24	Q/Q Change
Profit	$6.4M	↓ 8.18%

	FY19	Y/Y Change
Operating Cash Flow	$1.9M	↓ 251.88%
Investing Cash Flow	$-834.0K	↓ 31.97%
Financing Cash Flow	$1.2M	↑ 9153.85%

	FY20	Y/Y Change
Operating Cash Flow	$2.9M	↑ 56.02%
Investing Cash Flow	$-2.2M	↑ 166.19%
Financing Cash Flow	$4.4M	↑ 267.41%

	FY21	Y/Y Change
Operating Cash Flow	$-1.7M	↓ 157.87%
Investing Cash Flow	$-3.2M	↑ 42.75%
Financing Cash Flow	$1.2M	↓ 72.96%

	FY22	Y/Y Change
Operating Cash Flow	$6.5M	↓ 486.5%
Investing Cash Flow	$-2.4M	↓ 24.77%
Financing Cash Flow	$207.0K	↓ 82.68%

	FY23	Y/Y Change
Operating Cash Flow	$4.0M	↓ 39.13%
Investing Cash Flow	$-2.9M	↑ 20.47%
Financing Cash Flow	$11.0K	↓ 94.69%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-4.0M	↑ 462.91%
Investing Cash Flow	$-668.0K	↓ 12.11%
Financing Cash Flow	$-590.0K	↑ 686.67%

Champions Oncology Technicals Summary

Sell

Neutral

Buy

Champions Oncology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Champions Oncology (CSBR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Champions Oncology Inc	3.2%	143.06%	84.73%	21.1%	86.13%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Champions Oncology Inc	NA	NA	0.0	0.21	-1.55	-0.01	NA	0.05
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Champions Oncology Inc	Sell	$141.5M	86.13%	NA	-1.12%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Champions Oncology

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Organization	Champions Oncology
Employees	210
CEO	Dr. Ronnie Morris M.D.
Industry	Health Technology

Management People of Champions Oncology

Name	Title
Dr. Ronnie Morris M.D.	CEO & Director
Mr. David Barry Miller M.B.A.	Chief Financial Officer
Dr. Maria Mancini Ph.D.	Chief Operating Officer
Mr. Arthur Hanson	Vice President of Technology
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS	Vice President of Global Marketing
Dr. Michael Ritchie M.B.A., Ph.D.	Chief Commercial Officer
Dr. Karin Abarca Heidemann Ph.D.	Executive Vice President of Global Scientific Operations
Dr. Marianna Zipeto Ph.D.	Executive Vice President of Commercial, Research Services & Partnering

Important FAQs about investing in CSBR Stock from India :

What is Champions Oncology share price today?

Champions Oncology share price today stands at $10.40, Open: $10.30 ; Previous Close: $10.33 ; High: $10.62 ; Low: $10.00 ; 52 Week High: $11.99 ; 52 Week Low: $3.60.

The stock opens at $10.30, after a previous close of $10.33. The stock reached a daily high of $10.62 and a low of $10.00, with a 52-week high of $11.99 and a 52-week low of $3.60.

Can Indians buy Champions Oncology shares?

Yes, Indians can invest in the Champions Oncology (CSBR) from India.

With INDmoney, you can buy Champions Oncology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Champions Oncology at zero transaction cost.

How can I buy Champions Oncology shares from India?

It is very easy to buy Champions Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Champions Oncology (CSBR) be purchased?

Yes, you can buy fractional shares of Champions Oncology with INDmoney app.

What are the documents required to start investing in Champions Oncology stocks?

To start investing in Champions Oncology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.